series-c-plus
Stage
2
Investors
About
Kuros Biosciences is a Swiss-headquartered global biotech company that develops innovative biologic technologies and bone graft products, such as MagnetOs, to promote safer and more predictable bone healing in spine, extremities, trauma, and oncology applications.
Explore Kuros Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.